Yinhu Qingwen Granule in the Treatment of Viral Pneumonia

Status Not yet recruiting

Clinical Trial Summary

This is a non-randomized single arm clinical study to observe the effect of Yinhu Qingwen Granule in the relief of fever and improvement of related-symptoms of patients with viral pneumonia.

Clinical Trial Description

Preliminary pharmacodynamic and toxicological studies can show that Yinhu Qingwen Granule has a certain effect on pneumonia caused by various viruses, and its safety is good. This study aims to observe the effect of Yinhu Qingwen Granule in the relief of fever and improvement of related-symptoms of patients with viral pneumonia. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04955223
Study type	Interventional
Source	China Academy of Chinese Medical Sciences
Contact	Zhong Wang, M.D.
Phone	+861064093305
Email	zhonw@vip.sina.com
Status	Not yet recruiting
Phase	Early Phase 1
Start date	December 2022
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05286255` - Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias	Phase 1
Recruiting	`NCT04952337` - Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
Completed	`NCT04606407` - Inhaled NO for the Treatment of Viral Pneumonia in Adults	N/A
Not yet recruiting	`NCT05612893` - Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study
Not yet recruiting	`NCT04397497` - Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)	Phase 2
Terminated	`NCT04345289` - Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia	Phase 3
Enrolling by invitation	`NCT04326036` - Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection	Early Phase 1
Withdrawn	`NCT00645619` - Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
Completed	`NCT04385823` - Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure
Not yet recruiting	`NCT04876573` - Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19	Phase 2
Unknown status	`NCT01612572` - A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals	N/A
Completed	`NCT02152358` - PTH - Preemptive Treatment for Herpesviridae	Phase 4
Completed	`NCT04644302` - Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis
Recruiting	`NCT05531149` - Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia	Phase 3
Completed	`NCT01868113` - Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial	Phase 3
Recruiting	`NCT04380376` - Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia	Phase 2
Completed	`NCT05386459` - Study of the Use of the Drug Ingaron in Patients With COVID-19
Not yet recruiting	`NCT06349707` - Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
Completed	`NCT04394026` - Imaging Feature of SARS-CoV2 Infection
Not yet recruiting	`NCT04820751` - Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial	Phase 3